Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 16. November 2018
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1704  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 34064  
   
Comment on "Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer".
Dis Markers
Jayaraj R, Kumarasamy C, Madhav MR, Pandey V, Sabarimurugan S, Ramesh N, Gothandam KM, Baxi S.
PMID: 30425753 [PubMed - in process]


Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer.
Front Genet
Ndlovu R, Deng LC, Wu J, Li XK, Zhang JS.
PMID: 30425728 [PubMed]


Functions and clinical implications of exosomes in pancreatic cancer.
Biochim Biophys Acta Rev Cancer
Qian L, Yu S, Chen Z, Meng Z, Huang S, Wang P.
PMID: 30419313 [PubMed - as supplied by publisher]


A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.
Am J Clin Oncol
Ma WW, Xie H, Fetterly G, Pitzonka L, Whitworth A, LeVea C, Wilton J, Mantione K, Schihl S, Dy GK, Boland P, Iyer R, Tan W, Brady W, Straubinger RM, Adjei AA.
PMID: 30418178 [PubMed - as supplied by publisher]


Adolescent overweight and obesity and the risk for pancreatic cancer among men and women: a nationwide study of 1.79 million Israeli adolescents.
Cancer
Levi Z, Rottenberg Y, Twig G, Katz L, Leiba A, Derazne E, Tzur D, Eizenstein S, Keinan-Boker L, Afek A, Kark JD.
PMID: 30417331 [PubMed - as supplied by publisher]


GPRC5A: An Emerging Biomarker in Human Cancer.
Biomed Res Int
Jiang X, Xu X, Wu M, Guan Z, Su X, Chen S, Wang H, Teng L.
PMID: 30417009 [PubMed - in process]


Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-Transferase Pi expression for the efficacy and safety of FOLFIRINOX in patients with unresectable pancreatic cancer.
Am J Cancer Res
Tezuka S, Ueno M, Kobayashi S, Morimoto M, Ohkawa S, Hirotani A, Tozuka Y, Moriya S, Nakamura Y, Miyagi Y, Sugimori M, Maeda S.
PMID: 30416859 [PubMed]


Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives.
Cancer Treat Rev
Macchini M, Chiaravalli M, Zanon S, Peretti U, Mazza E, Gianni L, Reni M.
PMID: 30414985 [PubMed - as supplied by publisher]


Minimally Invasive Staging Surgery for Cancer.
Surg Oncol Clin N Am
Cohen NA, Kingham TP.
PMID: 30414682 [PubMed - in process]


Fluorescence Imaging for Minimally Invasive Cancer Surgery.
Surg Oncol Clin N Am
Ishizawa T, Saiura A.
PMID: 30414681 [PubMed - in process]


Endoscopic Management of Pancreatic Cancer.
Surg Oncol Clin N Am
Lee JH, Ahmed O.
PMID: 30414679 [PubMed - in process]


Histamine Receptors and Cancer Pharmacology: An Update.
Br J Pharmacol
Massari NA, Nicoud MB, Medina VA.
PMID: 30414378 [PubMed - as supplied by publisher]


High-grade Dysplasia in Resected Main-duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Am J Gastroenterol
Majumder S, Philip NA, Nagpal SJS, Takahashi N, Mara KC, Kendrick ML, Smyrk TC, Zhang L, Levy MJ, Gleeson FC, Petersen BT, Pearson RK, Topazian MD, Vege SS, Chari ST.
PMID: 30413822 [PubMed - as supplied by publisher]


The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
Medicine (Baltimore)
Ma JY, Ke LC, Liu Q.
PMID: 30412089 [PubMed - in process]


Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway.
Pathol Oncol Res
Ou X, Zhang GT, Xu Z, Chen JS, Xie Y, Liu JK, Liu XP.
PMID: 30411297 [PubMed - as supplied by publisher]


A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
Invest New Drugs
Saito K, Isayama H, Nakai Y, Takahara N, Ishigaki K, Takeda T, Hakuta R, Saito T, Uchino R, Kishikawa T, Hamada T, Mizuno S, Sasaki T, Kogure H, Matsubara S, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K.
PMID: 30411217 [PubMed - as supplied by publisher]


Mucinous cystic neoplasm diagnosed by EUS-guided microforceps biopsy.
Endosc Int Open
Orr J, Lockwood R, Salaria S, Gamboa A, Yachimski P.
PMID: 30410960 [PubMed]


MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
Trials
Hirono S, Kawai M, Okada KI, Fujii T, Sho M, Satoi S, Amano R, Eguchi H, Mataki Y, Nakamura M, Matsumoto I, Baba H, Tani M, Kawabata Y, Nagakawa Y, Yamada S, Murakami Y, Shimokawa T, Yamaue H.
PMID: 30409152 [PubMed - in process]


Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer.
J Gastroenterol
Kitano M, Yoshida T, Itonaga M, Tamura T, Hatamaru K, Yamashita Y.
PMID: 30406288 [PubMed - as supplied by publisher]


Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer.
Int J Mol Sci
Macherla S, Laks S, Naqash AR, Bulumulle A, Zervos E, Muzaffar M.
PMID: 30405053 [PubMed - in process]


   
   Artikel 1 - 20 / 34064    Seite 1 von 1704  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1